Peer Review History

Original SubmissionJuly 28, 2023
Decision Letter - Luc E. Coffeng, Editor, Eva Clark, Editor

Dear Professor Lundin,

Thank you very much for submitting your manuscript "Diagnostics of soil-transmitted helminths with digital mobile microscopy and artificial intelligence in a resource-limited setting" for consideration at PLOS Neglected Tropical Diseases. As with all papers reviewed by the journal, your manuscript was reviewed by members of the editorial board and by several independent reviewers. In light of the reviews (below this email), we would like to invite the resubmission of a significantly-revised version that takes into account the reviewers' comments.

We cannot make any decision about publication until we have seen the revised manuscript and your response to the reviewers' comments. Your revised manuscript is also likely to be sent to reviewers for further evaluation.

When you are ready to resubmit, please upload the following:

[1] A letter containing a detailed list of your responses to the review comments and a description of the changes you have made in the manuscript. Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out.

[2] Two versions of the revised manuscript: one with either highlights or tracked changes denoting where the text has been changed; the other a clean version (uploaded as the manuscript file).

Important additional instructions are given below your reviewer comments.

Please prepare and submit your revised manuscript within 60 days. If you anticipate any delay, please let us know the expected resubmission date by replying to this email. Please note that revised manuscripts received after the 60-day due date may require evaluation and peer review similar to newly submitted manuscripts.

Thank you again for your submission. We hope that our editorial process has been constructive so far, and we welcome your feedback at any time. Please don't hesitate to contact us if you have any questions or comments.

Sincerely,

Luc E. Coffeng, MD PhD

Guest Editor

PLOS Neglected Tropical Diseases

Eva Clark

Section Editor

PLOS Neglected Tropical Diseases

***********************

Reviewer's Responses to Questions

Key Review Criteria Required for Acceptance?

As you describe the new analyses required for acceptance, please consider the following:

Methods

-Are the objectives of the study clearly articulated with a clear testable hypothesis stated?

-Is the study design appropriate to address the stated objectives?

-Is the population clearly described and appropriate for the hypothesis being tested?

-Is the sample size sufficient to ensure adequate power to address the hypothesis being tested?

-Were correct statistical analysis used to support conclusions?

-Are there concerns about ethical or regulatory requirements being met?

Reviewer #1: The scientific obejctive of this work and the novelty is not clear enough. This should be improved upon accordingly.

The study design is good enought.

The population is clearly described and appropriate for the hypothesis being tested.

Statistical analyisis used are satisfactory

Appropriate ethical regulatory requirement has been met.

Reviewer #2: Methods

Line 121 and 122; do we need the abbreviations TUM and NACOSTI – they are only used once.

Line 128: no need to capitalize albendazole

Line 134: please refer to STARD-AI (see general comment) and adapt the manuscript were required.

Line 139: there were any inc/exclusion criteria

Fig 1: see STANDARD AI

Line 157: why can people other the reviewers not access this. I would like to encourage the authors to add them.

Line 165: there is systematic bias in the study design (see general comment)

Line 177: this exclusion of samples also needs to be discussed; in a way you are favoring for clear slides

Line 193: how long does it take to scan one slide

Line 212: per slide / all slides

Fig 2: Can you confirm the scanning automated?

Lines 223 – 232: this might require a review by a AI-expert

Lines 245: not clear whether all digitized slides (line 245) or only discrepancies (line 186-189)

Fig 4: see remark on definition, of ground truth

Line 277: can one indicate the number of slides per STH specfies; per set (training, valiation).

Line 294: please define the level of confidence

Statistical analysis

Line 309: The word ‘comparable’ suggests an equivalence testing

Line 314: not sure where the correlation refers to; I am assuming EPG; see also general comment.

Reviewer #3: The methods used in this paper are appropriate.

--------------------

Results

-Does the analysis presented match the analysis plan?

-Are the results clearly and completely presented?

-Are the figures (Tables, Images) of sufficient quality for clarity?

Reviewer #1: Details contained in the attachement

Reviewer #2: Results

See general comments on how results are represented

Would welcome more alignment with the hypothesis (‘comparable to the ground thruth).

Table 3. Replace AL by Ascaris lumbricoides

Reviewer #3: Results are clearly presented, and they correspond to the aims of this study.

--------------------

Conclusions

-Are the conclusions supported by the data presented?

-Are the limitations of analysis clearly described?

-Do the authors discuss how these data can be helpful to advance our understanding of the topic under study?

-Is public health relevance addressed?

Reviewer #1: Details contained in the attachement

Reviewer #2: Discussion

Line 400 – compared to the ground truth (manual microscopy) I would argue that the accuracy is not high; of course reviewing the discrepancies it does. Again, it might help to re-define ground truth.

Line 448 – perhaps it would be good to emphasize a health centre looks like; is indeed representative for a setting with poor infrastructure

How do the authors feel about the extrapolation of the findings to other setting

Reviewer #3: Yes

--------------------

Editorial and Data Presentation Modifications?

Use this section for editorial suggestions as well as relatively minor modifications of existing data that would enhance clarity. If the only modifications needed are minor and/or editorial, you may wish to recommend “Minor Revision” or “Accept”.

Reviewer #1: Details contained in the attachement

Reviewer #2: See general comments

Reviewer #3: (No Response)

--------------------

Summary and General Comments

Use this section to provide overall comments, discuss strengths/weaknesses of the study, novelty, significance, general execution and scholarship. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. If requesting major revision, please articulate the new experiments that are needed.

Reviewer #1: (No Response)

Reviewer #2: Lundin and colleagues assessed the performance of digital mobile microscopy supported with AI to detect and quantify STH eggs in KK thick-smear. For this, they conducted a study in a health center (Kenya), where stool samples for school-aged children (SAC) were processed by both manual microscopy and AI. Based on the study results, they conclude that digital mobile microscopy supported with AI holds promise as a diagnostic standard in health care settings.

General comments

1/ It is not clear to me where the authors position their invention. Is it to support program-decision making (determine the frequency and intensity of MDA), as highlighted in the introduction, or to support diagnosis in the health center, as concluded in the abstract. Both are not only quite distinct in decision making (population level vs. individual treatment) and field use (point-of-sampling vs. point of care), I also doubt whether Kato-Katz thick smear is the diagnostic standard in a health center. Too often this is just a direct smear, to ensure detection of a wider spectrum of parasites, including protozoa.

2/ The study design has some an important flaw: the slides were first subjected to manual microscopy, after which they were scanned. Given a time bounded procedure such as Kato-Katz (hookworm eggs disappear), this has some consequences. This might indeed explain why some hookworms were missed by DSL. Yet, it might also explain why some Ascaris and Trichuris eggs were detected by DSL but not by manual microscopy. While hookworm eggs disappear over time due to the stool clearing process, Ascaris and Trichuris eggs might become more visible over time. In other words, the improved accuracy might be solely due to a difference in clearing time. This is in particular when slides were immediately examined (line 165), and hence there is slides were not cleared at all. Study cannot be redone, but this should be explicitly mentioned in the discussion.

3/ I feel that result section misses some clarity/info. First, the word ground truth in an AI setting for manual reading is confusing. My interpretation of ground truth is that whole digitized slides are manually and independently annotated by preferable multiple independent experts. Ground truth is now used for manual microscopy (Table 3). Second, I would also propose to add a Table that represents that results after visual review of the digitized samples. This will help the reader to reasoning of the conclusions about the sensitivity/specificity. A sensitivity of 70 – 92% compared to manual microscopy is not really an improvement, whereas the visual review indicates that manual microscopy missed most of the positive samples detected by DLS. Third, I would welcome a scatter plot plotting the EPG for manual microscopy as a function of those obtained by DLS that could replace Table 4. Such a graph would give more insights in the data: (i) correlation in EPG between both diagnostics; (ii) where they fail compared to the other one (dots on the y-/x- axis), (iii) agreement in classification of infection intensity, and (iv) highlight the visual review results (this might require some thought).

4/ Appreciate the attention the authors give to report according to the STARD-guidelines. Given the involvement of AI, I would encourage them to also consult the STARD-AI guidelines (Sounderajah et al., 2021; BMC OPEN Protocol), and to adapt the manuscript accordingly.

5/ Author summary: propose to use more lay language. For example, intestinal worms instead of STHs.

Reviewer #3: Overall, the manuscript adds value to the literature for the detection of eggs of STH in developing countries by providing confidence of removing skilled personnel for microscopy. The methods are appropriate, results are presented nicely and interpreted carefully. Therefore, I recommend this paper for publication after a minor revision due to the following reasons:

Abbreviations used in some tables need to explained in footnotes.

Scale bars should be given for microscopic images

References should be checked for style and formatting as per the journal's guidelines.

--------------------

PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

Reviewer #3: No

Figure Files:

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at figures@plos.org.

Data Requirements:

Please note that, as a condition of publication, PLOS' data policy requires that you make available all data used to draw the conclusions outlined in your manuscript. Data must be deposited in an appropriate repository, included within the body of the manuscript, or uploaded as supporting information. This includes all numerical values that were used to generate graphs, histograms etc.. For an example see here: http://www.plosbiology.org/article/info%3Adoi%2F10.1371%2Fjournal.pbio.1001908#s5.

Reproducibility:

To enhance the reproducibility of your results, we recommend that you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. Additionally, PLOS ONE offers an option to publish peer-reviewed clinical study protocols. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols

Attachments
Attachment
Submitted filename: Review of the manuscript.docx
Revision 1

Attachments
Attachment
Submitted filename: Lundin_et_al_Response_Letter.docx
Decision Letter - Luc E. Coffeng, Editor, Eva Clark, Editor

Dear Professor Lundin,

Thank you very much for submitting your manuscript "Diagnostics of soil-transmitted helminths with digital mobile microscopy and artificial intelligence in a resource-limited setting" for consideration at PLOS Neglected Tropical Diseases. As with all papers reviewed by the journal, your manuscript was reviewed by members of the editorial board and by several independent reviewers. The reviewers appreciated the attention to an important topic. Based on the reviews, we are likely to accept this manuscript for publication, providing that you modify the manuscript according to the review recommendations.

Dear authors,

Thank you for addressing the three reviewer's comments. Two of the reviewers still have some points for (minor) revision, which I would like to ask you to address. Please note that one of the reviewers has listed their points in an attached pdf file (also downloadable from the online editorial system).

Please prepare and submit your revised manuscript within 30 days. If you anticipate any delay, please let us know the expected resubmission date by replying to this email.

When you are ready to resubmit, please upload the following:

[1] A letter containing a detailed list of your responses to all review comments, and a description of the changes you have made in the manuscript.

Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out

[2] Two versions of the revised manuscript: one with either highlights or tracked changes denoting where the text has been changed; the other a clean version (uploaded as the manuscript file).

Important additional instructions are given below your reviewer comments.

Thank you again for your submission to our journal. We hope that our editorial process has been constructive so far, and we welcome your feedback at any time. Please don't hesitate to contact us if you have any questions or comments.

Sincerely,

Luc E. Coffeng, MD PhD

Academic Editor

PLOS Neglected Tropical Diseases

Eva Clark

Section Editor

PLOS Neglected Tropical Diseases

***********************

Dear authors,

Thank you for addressing the three reviewer's comments. Two of the reviewers still have some points for (minor) revision, which I would like to ask you to address.

Reviewer's Responses to Questions

Key Review Criteria Required for Acceptance?

As you describe the new analyses required for acceptance, please consider the following:

Methods

-Are the objectives of the study clearly articulated with a clear testable hypothesis stated?

-Is the study design appropriate to address the stated objectives?

-Is the population clearly described and appropriate for the hypothesis being tested?

-Is the sample size sufficient to ensure adequate power to address the hypothesis being tested?

-Were correct statistical analysis used to support conclusions?

-Are there concerns about ethical or regulatory requirements being met?

Reviewer #1: The objectives of the study are clearly articulated. Further comments are included in the attachments.

Reviewer #2: (No Response)

--------------------

Results

-Does the analysis presented match the analysis plan?

-Are the results clearly and completely presented?

-Are the figures (Tables, Images) of sufficient quality for clarity?

Reviewer #1: (No Response)

Reviewer #2: (No Response)

--------------------

Conclusions

-Are the conclusions supported by the data presented?

-Are the limitations of analysis clearly described?

-Do the authors discuss how these data can be helpful to advance our understanding of the topic under study?

-Is public health relevance addressed?

Reviewer #1: (No Response)

Reviewer #2: (No Response)

--------------------

Editorial and Data Presentation Modifications?

Use this section for editorial suggestions as well as relatively minor modifications of existing data that would enhance clarity. If the only modifications needed are minor and/or editorial, you may wish to recommend “Minor Revision” or “Accept”.

Reviewer #1: (No Response)

Reviewer #2: (No Response)

--------------------

Summary and General Comments

Use this section to provide overall comments, discuss strengths/weaknesses of the study, novelty, significance, general execution and scholarship. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. If requesting major revision, please articulate the new experiments that are needed.

Reviewer #1: (No Response)

Reviewer #2: Lundin and colleagues have thoroughly revised the manuscript and addressed all my major comments. I only have a few minor comments suggestions that the authors may want to consider to further improve the manuscript.

Abstract

Line 21: there is a conflict in words; NTDs refers to diseases, while soil-transmitted helminths refer to the pathogens; better to use ‘soil-transmitted helminthiasis’ instead

Line 24: WHO target is not to eliminate STH, rather the elimination of STH as a public health problem.

Line 47: I think there is broad consensus that this not perfect. So I am not sure whether you can make this conclusion.

Author summary

Line 53: stool instead of feces

Introduction:

See previous comment on diseases vs. pathogen

Line 73: they are all roundworms, Ascaris is sometimes referred as giant roundworm

Line 83: prefer to state ‘recommended method’ or ‘current diagnostic standard’ instead of ‘gold standard’

Line 96: FECPAKG2 instead of FECPAK (this the first generation)

Line 97: not all of these have a higher sensitivity.

Line 118: ‘Kato-Katz thick smear’ instead of ‘faecal samples’

Line 119/line218: ‘smears’ instead of ‘samples’; check throughout the manuscript

Methods

Lin 161:

Line 171: mL instead of ml

Line 274: n = 388?

Line 264: Fig 3 instead of Figure

Line 343: what does epsilon means in these formulae?

Table 2: omit the row for deep learning; this is made clear in the caption

Line 405: Table S1 instead of S Table 1

Line 407: Fig S1 instead of S1 Figure

Lines 437 – 441: the core question is whether the classifications of infection intensity based on DLS would be different when using manual microscopy. This is more relevant than the difference in mean in EPG. I would like to see this in the body of the text instead of putting into it in supplementary info

Discussion

Line 453: avoid the use of gold standard

Line 492: the way forward would be either to randomize the KK slide over manual or WSI; or to prepare a duplicate slide which are then processed in parallel.

Line 518: put genus names in italic; note that the performance in the TPP are absolute, and not relative to the manual reading of KK, and hence may want to tune down the conclusions a bit down.

--------------------

PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

Figure Files:

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at figures@plos.org.

Data Requirements:

Please note that, as a condition of publication, PLOS' data policy requires that you make available all data used to draw the conclusions outlined in your manuscript. Data must be deposited in an appropriate repository, included within the body of the manuscript, or uploaded as supporting information. This includes all numerical values that were used to generate graphs, histograms etc.. For an example see here: http://www.plosbiology.org/article/info%3Adoi%2F10.1371%2Fjournal.pbio.1001908#s5.

Reproducibility:

To enhance the reproducibility of your results, we recommend that you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. Additionally, PLOS ONE offers an option to publish peer-reviewed clinical study protocols. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols

References

Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article's retracted status in the References list and also include a citation and full reference for the retraction notice.

Attachments
Attachment
Submitted filename: Review_TEA.pdf
Revision 2

Attachments
Attachment
Submitted filename: Letter of response Lundin et al revision2_060224.docx
Decision Letter - Eva Clark, Editor

Dear Professor Lundin,

We are pleased to inform you that your manuscript 'Diagnostics of soil-transmitted helminths with digital mobile microscopy and artificial intelligence in a resource-limited setting' has been provisionally accepted for publication in PLOS Neglected Tropical Diseases.

Before your manuscript can be formally accepted you will need to complete some formatting changes, which you will receive in a follow up email. A member of our team will be in touch with a set of requests.

Please note that your manuscript will not be scheduled for publication until you have made the required changes, so a swift response is appreciated.

IMPORTANT: The editorial review process is now complete. PLOS will only permit corrections to spelling, formatting or significant scientific errors from this point onwards. Requests for major changes, or any which affect the scientific understanding of your work, will cause delays to the publication date of your manuscript.

Should you, your institution's press office or the journal office choose to press release your paper, you will automatically be opted out of early publication. We ask that you notify us now if you or your institution is planning to press release the article. All press must be co-ordinated with PLOS.

Thank you again for supporting Open Access publishing; we are looking forward to publishing your work in PLOS Neglected Tropical Diseases.

Best regards,

Eva Clark, M.D., Ph.D.

Section Editor

PLOS Neglected Tropical Diseases

Eva Clark

Section Editor

PLOS Neglected Tropical Diseases

***********************************************************

Reviewer's Responses to Questions

Key Review Criteria Required for Acceptance?

As you describe the new analyses required for acceptance, please consider the following:

Methods

-Are the objectives of the study clearly articulated with a clear testable hypothesis stated?

-Is the study design appropriate to address the stated objectives?

-Is the population clearly described and appropriate for the hypothesis being tested?

-Is the sample size sufficient to ensure adequate power to address the hypothesis being tested?

-Were correct statistical analysis used to support conclusions?

-Are there concerns about ethical or regulatory requirements being met?

Reviewer #2: yes

Reviewer #3: (No Response)

**********

Results

-Does the analysis presented match the analysis plan?

-Are the results clearly and completely presented?

-Are the figures (Tables, Images) of sufficient quality for clarity?

Reviewer #2: yes

Reviewer #3: (No Response)

**********

Conclusions

-Are the conclusions supported by the data presented?

-Are the limitations of analysis clearly described?

-Do the authors discuss how these data can be helpful to advance our understanding of the topic under study?

-Is public health relevance addressed?

Reviewer #2: yes

Reviewer #3: (No Response)

**********

Editorial and Data Presentation Modifications?

Use this section for editorial suggestions as well as relatively minor modifications of existing data that would enhance clarity. If the only modifications needed are minor and/or editorial, you may wish to recommend “Minor Revision” or “Accept”.

Reviewer #2: (No Response)

Reviewer #3: (No Response)

**********

Summary and General Comments

Use this section to provide overall comments, discuss strengths/weaknesses of the study, novelty, significance, general execution and scholarship. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. If requesting major revision, please articulate the new experiments that are needed.

Reviewer #2: All comments are adessed.

Reviewer #3: (No Response)

**********

PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #2: No

Reviewer #3: No

Formally Accepted
Acceptance Letter - Eva Clark, Editor

Dear Professor Lundin,

We are delighted to inform you that your manuscript, "Diagnosis of soil-transmitted helminth infections with digital mobile microscopy and artificial intelligence in a resource-limited setting  ," has been formally accepted for publication in PLOS Neglected Tropical Diseases.

We have now passed your article onto the PLOS Production Department who will complete the rest of the publication process. All authors will receive a confirmation email upon publication.

The corresponding author will soon be receiving a typeset proof for review, to ensure errors have not been introduced during production. Please review the PDF proof of your manuscript carefully, as this is the last chance to correct any scientific or type-setting errors. Please note that major changes, or those which affect the scientific understanding of the work, will likely cause delays to the publication date of your manuscript. Note: Proofs for Front Matter articles (Editorial, Viewpoint, Symposium, Review, etc...) are generated on a different schedule and may not be made available as quickly.

Soon after your final files are uploaded, the early version of your manuscript will be published online unless you opted out of this process. The date of the early version will be your article's publication date. The final article will be published to the same URL, and all versions of the paper will be accessible to readers.

Thank you again for supporting open-access publishing; we are looking forward to publishing your work in PLOS Neglected Tropical Diseases.

Best regards,

Shaden Kamhawi

co-Editor-in-Chief

PLOS Neglected Tropical Diseases

Paul Brindley

co-Editor-in-Chief

PLOS Neglected Tropical Diseases

Open letter on the publication of peer review reports

PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.

We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.

Learn more at ASAPbio .